Increasing the dosage of Cosentyx (secukinumab) may affect the occurrence and severity of its side effects. However, it is important to note that everyone's response to medication can vary, and some people may experience different side effects even at the same dosage.
Cosentyx is a prescription medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It belongs to a class of drugs known as monoclonal antibodies, which work by targeting and blocking a specific protein in the body that contributes to inflammation [1].
Common side effects of Cosentyx include cold symptoms (such as runny or stuffy nose, sore throat), diarrhea, and upper respiratory tract infections [2]. Increasing the dosage of Cosentyx may increase the likelihood or severity of these side effects.
In addition, some people may experience more serious side effects from Cosentyx, such as allergic reactions, infections, or reactions at the injection site. While increasing the dosage may not directly cause these side effects, people who experience them may be at a higher risk of developing them again if the dosage is increased [2].
It is important to follow the dosage instructions provided by a healthcare professional, as increasing the dosage without medical supervision can lead to an increased risk of side effects. If a higher dosage is necessary, a healthcare professional will carefully consider the potential benefits and risks before making a recommendation.
In summary, increasing the dosage of Cosentyx may affect the occurrence and severity of side effects. While some people may experience an increase in common side effects, others may be at a higher risk of developing more serious side effects. It is important to follow the dosage instructions provided by a healthcare professional and to report any side effects to them as soon as possible.
Sources:
1. DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab) Drug Profile. Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>.
2. Cosentyx (secukinumab) Injection, for Subcutaneous Use [Prescribing Information]. (2021). Novartis Pharmaceuticals Corporation. Retrieved from <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf>.